Table 1

Participant demographics entering foot temperature monitoring program

Age at enrollment (years)60.5 (±11.7)
Sex (male)76.6% (59/77)
Height (meters)1.8 (±0.1)
Mass (kg)104 (±23)
BMI (kg/m2)32.6 (±7.1)
Diabetes mellitus type 1 (%)8.8 (6/77)
Diabetes mellitus type 2 (%)92.2 (71/77)
Diabetes mellitus duration (years)13.6 (±7.1)
Glycated hemoglobin (HbA1c) (mmol/mol)64 (±17)
Race
 Black63.6% (49/77)
 White31.2% (24/77)
 Hispanic5.2% (4/77)
Participants with chronic comorbidities
 Heart failure28.6% (22/77)
 Renal failure60.0% (46/77)
 Peripheral arterial disease23.4% (18/77)
 Peripheral neuropathy100% (77/77)
 Retinopathy51.9% (40/77)
 Cataracts58.4% (45/77)
 Glaucoma23.4% (18/77)
 Any vision impairing comorbidity72.7% (56/77)
Foot deformity
 Charcot arthropathy15.6% (12/77)
 Hallux malleus3.9% (3/77)
 Hallux valgus2.6% (2/77)
History of partial foot amputation at enrollment51.9% (40/77)
DFU healing to enrollment, months6.3 (±6.8)
Additional foot ulcer characteristics pre-enrollment are in table 2
  • BMI, body mass index; DFU, diabetic foot ulcer.